DLX2 promotes osteosarcoma epithelial-mesenchymal transition and doxorubicin resistance by enhancing HOXC8-CDH2 axis

Boya Zhang(Shanghai University), Weitao Yao(Shanxi Medical University)
iScience
October 19, 2023
Cited by 9


Related Papers